MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Evaluation of a novel Phosphodiesterase 5 inhibitor as a potential therapeutic agent in P301S transgenic mouse model of tauopathy.

    S. Elfarrash, S. Eldusoky, M. Abdel-Halim, M. Salama, S. El-Khodery, M. Youssef (Mansoura, Egypt)

    Objective: In the current study, we evaluated a newly developed compound with a 1,3,5-trisubstituted pyrazoline scaffold with an improved PDE5 inhibitory potency as a potential…
  • 2023 International Congress

    Drug-induced Parkinsonism and nonmotor symptoms: a case of gustatory rhinorrhea

    S. Casanova, A. Cabral, M. Branco (Vila Nova Gaia, Portugal)

    Objective: We aim to emphasize the relevance of contemplating nonmotor symptoms as possible features of drug-induced parkinsonism, and the utmost importance of further investigation in…
  • 2023 International Congress

    Childhood-onset writer’s cramp evolving to generalised dystonia –a new mutation in KMT2B gene

    M. Sequeira, M. Soares, J. Rosa (Lisboa, Portugal)

    Objective: To present a case of childhood-onset dystonia with a new mutation in KMT2B gene. Background: KMT2B-related dystonia (DYT-KMT2B) is an increasingly recognized cause of…
  • 2023 International Congress

    Diabetic striatopathy presenting without hyperkinetic movements

    S. Bhalja, C. Sarvakar, S. Garg (Ahmedabad, India)

    Objective: To demonstrate a case of Diabetic striatopathy presenting without hyperkinetic movements Background: Diabetic striatopathy is an uncommon neurological complication associated with poorly controlled Diabetes Mellitus…
  • 2023 International Congress

    Stiff-Person Syndrome: Diagnosis and Experimental Models

    D. Labunskiy, S. Kiryukhina, N. Kolmykova, N. Kurgaev (Saransk, Russian Federation)

    Objective: Locked-in syndrome is a syndrome that is characterized by the lack of an adequate response of the patient to external, including verbal, stimuli due…
  • 2023 International Congress

    A randomized, phase 2a, double-blind, placebo-controlled clinical trial with NE3107 adjunctive to carbidopa/levodopa in patients with Parkinson’s disease

    J. Aldred, R. Rodriguez, E. Rivera-Rivera, S. Isaacson, R. Kumar, A. Ellenbogen, C. Ahlem, C. Reading, J. Palumbo, N. Osman, A. Lang (Spokane, USA)

    Objective: To evaluate the motor effects of NE3107 treatment in patients with levodopa-treated Parkinson’s disease (PD) experiencing motor fluctuations. Background: NE3107 is an oral, blood-brain…
  • 2023 International Congress

    Linking volume of tissue activated to neural oscillations in deep brain stimulation

    A. Kutuzova, C. Graef, B. Lonergan, Y. Tai, S. Haar (London, United Kingdom)

    Objective: Exploring the effect of deep brain stimulation (DBS) settings on neural oscillations in Parkinson’s disease (PD) patients with subthalamic nucleus (STN) DBS and their…
  • 2023 International Congress

    Differential effect of MAPT haplotype on survival in CBD and PSP-SCB phenotype

    A. Gharbi, I. Sghaier, I. Kacem, S. Mrabet, A. Souissi, A. Gargouri, A. Nasri, R. Gouider (Tunis, Tunisia)

    Objective: Evaluate the association of MAPT haplotype with the risk of PSP-CBS and CBD severity of tau pathology by studying the survival rate of both…
  • 2023 International Congress

    A comparison of national data on Parkinson’s disease mortality between the USA and UK

    N. Smati, W. Lintiso, E. Shamim (Gaithersburg, USA)

    Objective: To evaluate recent mortality trends in Parkinson’s Disease (PD) between the United States of America (USA) and the United Kingdom (UK) per national healthcare…
  • 2023 International Congress

    3D Multi-Delay pCASL to Understand Perfusion Changes in Patients with Parkinson’s disease with Mild Cognitive Impairment

    B. Thomas, Z. Mari, V. Mishra (Dallas, USA)

    Objective: To understand perfusion changes in patients with Parkinson’s disease (PD) with well-characterized mild cognitive impairment (MCI) using 3D multi-delay pseudo-continuous Arterial Spin Labeling (pCASL)…
  • « Previous Page
  • 1
  • …
  • 597
  • 598
  • 599
  • 600
  • 601
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley